IP Library Granted Patent US 7,807,440
Granted Patent B2
US 7,807,440 · App. 11/662,288 · Granted Oct 5, 2010

Probiotic

Assignee: Probi AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,440
App. No.
11/662,288
Granted
Oct 5, 2010
Kind
B2
Abstract

The present invention relates to a probiotic bacterial strain belonging to the genus Lactobacillus having the ability to colonize the human vagina, or a variant thereof. More specifically the probiotic bacterial strain belongs to a species chosen from the group comprising Lactobacillus plantarum, Lactobacillus crispatus , and Lactobacillus gasseri . Further it relates to its use as a medicament, a composition comprising the strain, the composition, e.g., being a food product or a pharmaceutical composition, a hygiene product, a biological pure culture of the strain, and a novel food.

Claims (35)

1. An isolated probiotic strain selected from the group consisting of Lactobacillus crispatus VPC5, which is deposited as DSM 16735 , Lactobacillus crispatus VPC40, which is deposited as DSM 16736 , Lactobacillus crispatus VPC70, which is deposited as DSM 16738 , Lactobacillus crispatus VPC71, which is deposited as DSM 16739 , Lactobacillus crispatus VPC77, which is deposited as DSM 16740 , Lactobacillus crispatus VPC111, which is deposited as DSM 16741 , Lactobacillus crispatus VPC130, which is deposited as DSM 16742 , Lactobacillus crispatus VPC177, which is deposited as DSM 16743, and Lactobacillus gasseri VPG44, which is deposited as DSM 16737.

2. The probiotic bacterial strain according to claim 1 , wherein said probiotic bacterial strain is viable.

3. A composition comprising:

(a) at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus crispatus VPC5, which is deposited as DSM 16735 , Lactobacillus crispatus VPC40, which is deposited as DSM 16736 , Lactobacillus crispatus VPC70, which is deposited as DSM 16738 , Lactobacillus crispatus VPC71, which is deposited as DSM 16739 , Lactobacillus crispatus VPC77, which is deposited as DSM 16740 , Lactobacillus crispatus VPC111, which is deposited as DSM 16741 , Lactobacillus crispatus VPC130, which is deposited as DSM 16742 , Lactobacillus crispatus VPC 177, which is deposited as DSM 16743, and Lactobacillus gassed VPG44, which is deposited as DSM 16737; and

(b) optionally, at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus plantarum HEAL 9, which is deposited as DSM 15312, Lactobacillus plantarum HEAL 19, which is deposited as DSM 15313, and Lactobacillus plantarum HEAL 99, which is deposited as DSM 15316.

4. The composition according to claim 3 , wherein said composition further comprises a carrier material.

5. The composition according to claim 3 , wherein said composition is a food product.

6. The composition according to claim 3 , wherein said composition is a food supplement.

7. The composition according to claim 4 , wherein said carrier material is selected from the group consisting of oat meal gruel, lactic acid fermented foods, resistant starch, dietary fibers, inulines, carbohydrates, proteins and glycolsylated proteins.

8. The composition according to claim 5 , wherein said food product is selected from the group consisting of bread, cheese, yogurt, juice, health bars, spreads, biscuits and cereals.

9. The composition according to claim 4 , wherein said at least one probiotic bacterial strain is encapsulated or coated.

10. The composition according to claim 4 , wherein said at least one probiotic bacterial strain is present in an amount giving, when consumed, an effective daily dose of 10 7 to 10 12 CFU.

11. The composition according to claim 3 , wherein said composition is a pharmaceutical composition.

12. The composition according to claim 11 , wherein said composition is administered orally, vaginally or rectally, or instilled into the urinary bladder.

13. The composition according to claim 11 , wherein said composition is administered in a combined treatment of orally and vaginally, orally and rectally, or orally, vaginally and rectally.

14. The composition according to claim 11 , wherein said carrier material is at least one pharmaceutically acceptable carrier.

15. The composition according to claim 11 , wherein said composition is administered in a form selected from the group consisting of tablets, sucking tablets, sweets, chewing gum, capsules, enterocoated tablets and capsules, suppositories, micro-enemas, vaginal tablets, vaginal gelatin capsules, vaginal troches, cream, gel, ointment, lotion, tampons, napkins, pads, melting strips, condoms, pessaries, sprays and clinical nutrition products.

16. The composition according to claim 11 , wherein said composition is administered orally, and wherein said at least one probiotic bacterial strain is present in an amount giving an effective daily dose of from 10 7 to 10 12 CFU.

17. The composition according to claim 11 , wherein said composition is administered vaginally or rectally, and wherein said at least one probiotic bacterial strain is present in an amount giving an effective daily dose of from 10 3 to 10 12 CFU.

18. The composition according to claim 11 , wherein said at least one probiotic bacterial strain is encapsulated or coated.

19. The composition according to claim 3 , wherein said composition further comprises additives selected from the group consisting of vitamins, minerals and probiotics.

20. A hygiene product comprising a composition according to claim 3 .

21. The hygiene product according to claim 20 , wherein said hygiene product is selected from the group consisting of tampons, sanitary napkins, sanitary pads, diapers, soaps, shampoos, gels, ointments, creams, sprays and lotions.

22. A biological culture comprising:

(a) at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus crispatus VPC5, which is deposited as DSM 16735 , Lactobacillus crispatus VPC40, which is deposited as DSM 16736 , Lactobacillus crispatus VPC70, which is deposited as DSM 16738 , Lactobacillus crispatus VPC71, which is deposited as DSM 16739 , Lactobacillus crispatus VPC77, which is deposited as DSM 16740 , Lactobacillus crispatus VPC111, which is deposited as DSM 16741 , Lactobacillus crispatus VPC130, which is deposited as DSM 16742 , Lactobacillus crispatus VPC177, which is deposited as DSM 16743, and Lactobacillus gasseri VPG44, which is deposited as DSM 16737; and

(b) optionally, at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus plantarum HEAL 9, which is deposited as DSM 15312 , Lactobacillus plantarum HEAL 19, which is deposited as DSM 15313, and Lactobacillus plantarum HEAL 99, which is deposited as DSM 15316.

23. A food comprising:

(a) at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus crispatus VPC5, which is deposited as DSM 16735 , Lactobacillus crispatus VPC40, which is deposited as DSM 16736 , Lactobacillus crispatus VPC70, which is deposited as DSM 16738 , Lactobacillus crispatus VPC71, which is deposited as DSM 16739 , Lactobacillus crispatus VPC77, which is deposited as DSM 16740 , Lactobacillus crispatus VPC111, which is deposited as DSM 16741 , Lactobacillus crispatus VPC130, which is deposited as DSM 16742 , Lactobacillus crispatus VPC177, which is deposited as DSM 16743 , Lactobacillus gasseri VPG44, which is deposited as DSM 16737; and

(b) optionally, at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus plantarum HEAL 9, which is deposited as DSM 15312 , Lactobacillus plantarum HEAL 19, which is deposited as DSM 15313, and Lactobacillus plantarum HEAL 99, which is deposited as DSM 15316.

24. A food supplement comprising:

(a) at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus crispatus VPC5, which is deposited as DSM 16735 , Lactobacillus crispatus VPC40, which is deposited as DSM 16736 , Lactobacillus crispatus VPC70, which is deposited as DSM 16738 , Lactobacillus crispatus VPC71, which is deposited as DSM 16739 , Lactobacillus crispatus VPC77, which is deposited as DSM 16740 , Lactobacillus crispatus VPC111, which is deposited as DSM 16741 , Lactobacillus crispatus VPC130, which is deposited as DSM 16742 , Lactobacillus crispatus VPC177, which is deposited as DSM 16743 , Lactobacillus gasseri VPG44, which is deposited as DSM 16737; and

(b) optionally, at least one isolated probiotic bacterial strain selected from the group consisting of Lactobacillus plantarum HEAL 9, which is deposited as DSM 15312 , Lactobacillus plantarum HEAL 19, which is deposited as DSM 15313, and Lactobacillus plantarum HEAL 99, which is deposited as DSM 15316.

25. The composition according to claim 7 , wherein said food product is selected from the group consisting of bread, cheese, yogurt, juice, health bars, spreads, biscuits and cereals.

26. The composition according to claim 4 , wherein said at least one probiotic bacterial strain is present in an amount giving, when consumed, an effective daily dose of 10 9 to 10 10 CFU.

27. The composition according to claim 11 , wherein said composition is administered orally, and wherein said at least one probiotic bacterial strain is present in an amount giving an effective daily dose of from 10 9 to 10 10 CFU.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2007
From: MOLIN, GORAN; AHRNE, SIV; JEPPSSON, BENGT; VASQUEZ, ALEJANDRA; BERGGREN, ANNA
To: PROBI AB
Reel/Frame 019156/0271 →
Priority Claims (1)
SE 0402406 · Oct 5, 2004 · national
Continuity (1)
Related Publication 20080268006A1 · Oct 30, 2008